Drug intelligence / Profile preview

MTPI (TPI monomer)

Development stage: Unknown
Modality: Small Molecules

Overview

MTPI, a tetraphenylimidazole (TPI) monomer, is an amphiphilic fluorophore designed for wash-free cell plasma membrane imaging. It functions as a fluorescent molecular rotor, exhibiting minimal fluorescence in aqueous environments but significantly enhanced emission in high-viscosity media. Its amphiphilic properties enable stable anchoring within anionic micelles/vesicles, which activates its intense fluorescence, making it suitable for visualizing cell plasma membranes.

Other names: TPI monomertetraphenylimidazole monomer

Beyond the preview

Go deeper on MTPI (TPI monomer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTPI (TPI monomer).

Explore the full profile